Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
of its most advanced generation stent, XIENCE Skypoint, in India. The launch is designed to equip doctors in the country with stents that can reach difficult areas and treat a wide range of blockages. Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India XIENCE Skypoint stents are more flexible and easier to guide through heart arteries, including large vessels. Expected to be of great benefit to doctors treating cardiovascular diseases, the stents are also suited for treating complex heart blockages. XIENCE Skypoint stands out for its slim, smooth delivery system, which helps doctors guide the stent through the vessel. It also includes a left main indication that helps doctors treat critical segments of the coronary artery. Abbott is to offer the broadest matrix ever from the XIENCE family to support the treatment of long lesions. It will also help reduce the number of stents required per procedure. The ultimate goal is to offer doctor
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Diabetes And Cardiology Updates Test Growth Story For Investors [Yahoo! Finance]Yahoo! Finance
- This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Invesco Rising Dividends Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- How The Story On Abbott Laboratories (ABT) Is Shifting As Analysts Rework Targets And Risks [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website